litlas
Log inCreate account

Lisbeth Illum

Active 1982–2021

86
Papers
20,387
Citations
81
h-index
86
i10-index

Citations

Citations per year for Lisbeth Illum1984: 2 citations1986: 4 citations1987: 7 citations1988: 15 citations1989: 4 citations1990: 20 citations1991: 20 citations1992: 14 citations1993: 41 citations1994: 43 citations1995: 75 citations1996: 57 citations1997: 67 citations1998: 116 citations1999: 104 citations2000: 101 citations2001: 191 citations2002: 134 citations2003: 179 citations2004: 216 citations2005: 238 citations2006: 220 citations2007: 219 citations2008: 266 citations2009: 290 citations2010: 218 citations2011: 234 citations2012: 219 citations2013: 205 citations2014: 254 citations2015: 179 citations2016: 169 citations2017: 149 citations2018: 190 citations2019: 478 citations2020: 515 citations2021: 498 citations2022: 382 citations2023: 246 citations2024: 299 citations2025: 188 citations2026: 1 citations1985: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,006 citing papers, 17.2% of this breakdownIndia: 634 citing papers, 10.8% of this breakdownChina: 566 citing papers, 9.7% of this breakdownUnited Kingdom: 343 citing papers, 5.8% of this breakdownItaly: 243 citing papers, 4.1% of this breakdownGermany: 204 citing papers, 3.5% of this breakdownFrance: 162 citing papers, 2.8% of this breakdownCanada: 152 citing papers, 2.6% of this breakdownEgypt: 140 citing papers, 2.4% of this breakdownSouth Korea: 136 citing papers, 2.3% of this breakdownSpain: 135 citing papers, 2.3% of this breakdownAustralia: 127 citing papers, 2.2% of this breakdown
0%17.2%Other 34.3%

Institutions

Fields

  • Pharmacology, Toxicology and Pharmaceutics37.6%
  • Materials Science18.9%
  • Medicine16.2%
  • Biochemistry, Genetics and Molecular Biology12.9%
  • Immunology and Microbiology3.1%
  • Neuroscience3%
  • Other8.3%

Topics

  • Advanced Drug Delivery Systems17.7%
  • Nanoparticle-Based Drug Delivery8%
  • RNA Interference and Gene Delivery5.8%
  • Advancements in Transdermal Drug Delivery4.7%
  • Drug Solubulity and Delivery Systems4.4%
  • Lipid Membrane Structure and Behavior2.8%
  • Other56.6%

Coauthors

All papers

Open in search
  1. Nanoparticles for direct nose-to-brain delivery of drugs

    Authors: Alpesh Mistry, Snow Stolnik, Lisbeth Illum - International Journal of Pharmaceutics 2009 cited by 720

  2. Nasal drug delivery—possibilities, problems and solutions

    Authors: Lisbeth Illum - Journal of Controlled Release 2003 cited by 1,085

  3. Transport of drugs from the nasal cavity to the central nervous system

    Authors: Lisbeth Illum - European Journal of Pharmaceutical Sciences 2000 cited by 887

  4. Intranasal delivery: Physicochemical and therapeutic aspects

    Authors: Henry R. Costantino, Lisbeth Illum, Gordon Brandt, Paul H. Johnson, Steven C. Quay - International Journal of Pharmaceutics 2007 cited by 597

  5. Chitosan in nasal delivery systems for therapeutic drugs

    Authors: Luca Casettari, Lisbeth Illum - Journal of Controlled Release 2014 cited by 431

  6. Nasal drug delivery: new developments and strategies

    Authors: Lisbeth Illum - Drug Discovery Today 2002 cited by 433

  7. Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solution

    Authors: Driton Vllasaliu, Ruth Exposito-Harris, Ángeles Heras, Luca Casettari, Martin C. Garnett, Lisbeth Illum, Snow Stolnik - International Journal of Pharmaceutics 2010 cited by 250

  8. Nose-to-Brain Delivery: Investigation of the Transport of Nanoparticles with Different Surface Characteristics and Sizes in Excised Porcine Olfactory Epithelium

    Authors: Alpesh Mistry, Snow Stolnik, Lisbeth Illum - Molecular Pharmaceutics 2015 cited by 177

  9. Chitosan as a novel nasal delivery system for vaccines

    Authors: Lisbeth Illum, Inderjit Jabbal‐Gill, M. Hinchcliffe, A.N. Fisher, S.S. Davis - Advanced Drug Delivery Reviews 2001 cited by 750

  10. Is nose-to-brain transport of drugs in man a reality?

    Authors: Lisbeth Illum - Journal of Pharmacy and Pharmacology 2004 cited by 437

  11. Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium

    Authors: Alpesh Mistry, Sys Zoffmann Glud, Jørgen Kjems, Jens Randel, Kenneth A. Howard, Snow Stolnik, Lisbeth Illum - Journal of drug targeting 2009 cited by 129

  12. PEGylated chitosan derivatives: Synthesis, characterizations and pharmaceutical applications

    Authors: Luca Casettari, Driton Vllasaliu, Enzo Castagnino, Snow Stolnik, Steven M. Howdle, Lisbeth Illum - Progress in Polymer Science 2011 cited by 255

  13. Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?

    Authors: Mattia Tiboni, Luca Casettari, Lisbeth Illum - International Journal of Pharmaceutics 2021 cited by 125

  14. In vitro evaluation of the mucoadhesive properties of chitosan microspheres

    Authors: Ping He, Stanley S. Davis, Lisbeth Illum - International Journal of Pharmaceutics 1998 cited by 658

  15. Nasal drug delivery — Recent developments and future prospects

    Authors: Lisbeth Illum - Journal of Controlled Release 2012 cited by 282

  16. Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update

    Authors: Sam Maher, David J. Brayden, Luca Casettari, Lisbeth Illum - Pharmaceutics 2019 cited by 156

  17. Distribution and clearance of bioadhesive formulations from the olfactory region in man: Effect of polymer type and nasal delivery device

    Authors: S.T. Charlton, Nick S. Jones, S.S. Davis, Lisbeth Illum - European Journal of Pharmaceutical Sciences 2006 cited by 110

  18. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation

    Authors: H.M. Redhead, S.S. Davis, Lisbeth Illum - Journal of Controlled Release 2001 cited by 414

  19. Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles

    Authors: A. M. Dyer, M. Hinchcliffe, Peter Watts, Jonathan Castile, Inderjit Jabbal‐Gill, Richard Nankervis, Alan M. Smith, Lisbeth Illum - Pharmaceutical Research 2002 cited by 281

  20. Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)

    Authors: Per Artursson, Tuulikki Lindmark, Stanley S. Davis, Lisbeth Illum - Pharmaceutical Research 1994 cited by 770

  21. Absorption Enhancers for Nasal Drug Delivery

    Authors: Stanley S. Davis, Lisbeth Illum - Clinical Pharmacokinetics 2003 cited by 265

  22. Clearance characteristics of chitosan based formulations in the sheep nasal cavity

    Authors: R. J. Soane, M. Hinchcliffe, S.S. Davis, Lisbeth Illum - International Journal of Pharmaceutics 2001 cited by 162

  23. Evaluation of the clearance characteristics of bioadhesive systems in humans

    Authors: R. J. Soane, M. Frier, Alan C. Perkins, Nicholas S. Jones, S.S. Davis, Lisbeth Illum - International Journal of Pharmaceutics 1999 cited by 359

  24. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: Influence of particle size and hydrophilic coating

    Authors: S. Moein Moghimi, Christopher J. H. Porter, I.S. Muir, Lisbeth Illum, S.S. Davis - Biochemical and Biophysical Research Communications 1991 cited by 281